June 12, 2013—Medicaid officials in three states have recently issued provider bulletins clarifying the procedures for billing 340B drugs used for fee for service (FFS) and managed care beneficiaries.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)